Hester Biosciences trades jubilantly on tying up with Gujarat government to explore production of COVID-19 vaccine

Hester Biosciences is currently trading at Rs. 2824.30, up by 354.25 points or 14.34% from its previous closing of Rs. 2470.05 on the BSE.

The scrip opened at Rs. 2623.00 and has touched a high and low of Rs. 2955.90 and Rs. 2623.00 respectively. So far 23003 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2,955.90 on 17-May-2021 and a 52 week low of Rs. 1070.00 on 15-May-2020.

Last one week high and low of the scrip stood at Rs. 2,955.90 and Rs. 2142.95 respectively. The current market cap of the company is Rs. 2398.94 crore.

The promoters holding in the company stood at 53.73%, while Institutions and Non-Institutions held 1.42% and 44.84% respectively.

Hester Biosciences has tied up with the Gujarat government to explore the production of the COVID-19 vaccine through technology transfer from Bharat Biotech. It has already initiated discussions with Bharat Biotech in this regard. A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine through technology from Bharat Biotech.

The discussions are currently ongoing with Bharat Biotech towards reviewing the infrastructure at Hester, the technology adaption process and the regulatory compliances.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.